New drug combo aims to shrink Hard-to-Treat cancers
Disease control
Not yet recruiting
This study tests an experimental drug called LRK-4189, given alone or with standard chemotherapy, for adults with advanced solid tumors that have not responded to prior treatment. The main goal is to check the drug's safety and find the best dose. About 120 participants will take…
Phase: PHASE1, PHASE2 • Sponsor: LARKSPUR BIOSCIENCES, INC. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC